Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
Chimerigen
CD152 [CTLA-4] (human):Fc (mouse) (rec.)
Product Details | |
---|---|
Synonyms | CTLA-4 |
Product Type | Protein |
Properties | |
Source/Host | CHO cells |
Sequence |
The extracellular domain of human CD152 [CTLA-4] (aa 37-160) is fused to the N-terminus of the Fc region of mouse IgG2a. |
Crossreactivity | Human |
Biological Activity |
Measured by its ability to inhibit IL-2 secretion by stimulated Jurkat human acute T cell leukemia cells. |
Purity | ≥98% (SDS-PAGE) |
Endotoxin Content | <0.06EU/μg protein (LAL test; Lonza). |
Reconstitution |
Reconstitute with 100 µl sterile water. Add 1X PBS to the desired protein concentration. |
Formulation | Lyophilized from 0.2μm-filtered solution in PBS. |
Protein Negative Control | |
Other Product Data |
NCBI reference NP_005205.2: CD152 (human) |
Declaration | Manufactured by Chimerigen. |
Shipping and Handling | |
Shipping | BLUE ICE |
Short Term Storage | +4°C |
Long Term Storage | -20°C |
Handling Advice |
Avoid freeze/thaw cycles. Centrifuge lyophilized vial before opening and reconstitution. |
Use/Stability |
Stable for at least 1 year after receipt when stored at -20°C. Working aliquots are stable for up to 3 months when stored at -20°C. |
Documents | |
MSDS | Inquire |
Product Specification Sheet | |
Datasheet | Download PDF |
CD152 [CTLA-4] and CD28, together with their ligands B7-1 and B7-2, constitute one of the dominant costimulatory pathways that regulate T and B cell responses. CD152 and CD28 are structurally homologous molecules that are members of the immunoglobulin (Ig) gene superfamily. Both CD152 and CD28 are composed of a single Ig V-like extracellular domain, a transmembrane domain and an intracellular domain. CD152 and CD28 are both expressed on the cell surface as disulfide-linked homodimers or as monomers. CD152 was originally identified as a gene that was specifically expressed by cytotoxic T lymphocytes. However, CD152 transcripts have since been found in both Th1 and Th2, and CD4+ and CD8+ T cell clones. Whereas, CD28 expression is constitutive on the surfaces of 95% of CD4+ T cells and 50% of CD8+ T cells and is down regulated upon T cell activation, CD152 expression is upregulated rapidly following T cell activation and peaks approximately 24 hours following activation. Although both CD152 and CD28 can bind to the same ligands, CD152 binds to B71 and B72 with 20-100-fold higher affinity than CD28.
- Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg: D.J. Lenschow, et al.; Science 257, 789 (1992)
- Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement: V.L. Perez, et al.; Immunity 6, 411 (1997)
- Ligation of B7-1/B7-2 by Human CD4 T Cells Triggers Indoleamine 2,3-Dioxygenase Activity in Dendritic Cells: D.H. Munn, et al.; J. Immunol. 172, 4100 (2004)
- CD28 delivers a unique signal leading to the selective recruitment of RelA and p52 NF-kappaB subunits on IL-8 and Bcl-xL gene promoters: B. Marinari, et al.; PNAS 101, 6098 (2004)
- An engineered lipocalin specific for CTLA-4 reveals a combining site with structural and conformational features similar to antibodies: D. Schönfeld, et al.; PNAS 106, 8198 (2009)